Frontiers in Pharmacology | Respiratory Pharmacology

Correction

Published on 02 Dec 2022

Corrigendum: Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF–HuR complex

in Respiratory Pharmacology

Qi Zhu
Jing Wang
Yunxia Ji
Jianlin Luan
Dayong Yue
Weili Liu
Hongbo Li
Jinjin Zhang
Guiwu Qu
Changjun Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1086927

1,839 views

Review

Published on 02 Dec 2022

Human matters in asthma: Considering the microbiome in pulmonary health

in Respiratory Pharmacology

Sandesh J. Marathe
Mark A. Snider
Armando S. Flores-Torres
Patricia J. Dubin
Amali E. Samarasinghe

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1020133

7,008 views
8 citations

Original Research

Published on 29 Nov 2022

Inhaled platelet vesicle-decoyed biomimetic nanoparticles attenuate inflammatory lung injury

in Respiratory Pharmacology

Hua Jin
Renxing Luo
Jianing Li
Hongxia Zhao
Suidong Ouyang
Yinlian Yao
Dongyan Chen
Zijie Ling
Weicong Zhu
Meijun Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1050224

6,566 views
15 citations

Original Research

Published on 29 Nov 2022

Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Hui Li
Jing Yang
Shanshan Chen
Peile Wang
Xueqing Yu
Qingwei Zhou
Xiaojian Zhang
Guojun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1055702

2,639 views
5 citations

Original Research

Published on 28 Nov 2022

Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Guirui Huang
Shuaiyang Huang
Hongsheng Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2022.993567

3,564 views
12 citations

Original Research

Published on 23 Nov 2022

Erythromycin attenuates oxidative stress-induced cellular senescence via the PI3K-mTOR signaling pathway in chronic obstructive pulmonary disease

in Respiratory Pharmacology

Yi Xiaofei
Li Tingting
Wei Xuan
He Zhiyi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1043474

3,941 views
14 citations

Original Research

Published on 18 Nov 2022

Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice

in Respiratory Pharmacology

Yanrong Long
Hongbin Chen
Junchao Deng
Junjie Ning
Pengbo Yang
Lina Qiao
Zhongwei Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1039103

4,010 views
6 citations

Review

Published on 16 Nov 2022

The protective effect of natural medicines against excessive inflammation and oxidative stress in acute lung injury by regulating the Nrf2 signaling pathway

in Respiratory Pharmacology

Rumei Luan
Dongyan Ding
Junling Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1039022

4,200 views
26 citations

Original Research

Published on 16 Nov 2022

Yangyinqingfei decoction attenuates PM2.5-induced lung injury by enhancing arachidonic acid metabolism

in Respiratory Pharmacology

Chunlan Tang
Yuqing Tang
Qinwen Wang
Donghui Chu
Jinyue Zhou
Yuping Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1056078

2,681 views
9 citations

Review

Published on 15 Nov 2022

Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment

in Respiratory Pharmacology

Tingwei Zhang
Jinjin Zhang
Changjun Lv
Hongbo Li
Xiaodong Song

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1059434

6,814 views
15 citations

Original Research

Published on 11 Nov 2022

Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation

in Respiratory Pharmacology

Shiu-Wan Chan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1007527

5,828 views
9 citations

Original Research

Published on 07 Nov 2022

Optimizing antidotal treatment with the oral HSP90 inhibitor TAS-116 against hydrochloric acid-induced pulmonary fibrosis in mice

in Respiratory Pharmacology

Pavel A. Solopov
Ruben Manuel Luciano Colunga Biancatelli
Christiana Dimitropolou
Tierney Day
John D. Catravas

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1034464

2,350 views
9 citations

Editorial

Published on 07 Nov 2022

Editorial: Insights in respiratory pharmacology: 2021

in Respiratory Pharmacology

Paolo Montuschi
Irfan Rahman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1052994

1,888 views

Review

Published on 03 Nov 2022

Highway to heal: Influence of altered extracellular matrix on infiltrating immune cells during acute and chronic lung diseases

in Respiratory Pharmacology

Mugdha M. Joglekar
Mehmet Nizamoglu
YiWen Fan
Sai Sneha Priya Nemani
Markus Weckmann
Simon D. Pouwels
Irene H. Heijink
Barbro N. Melgert
Janesh Pillay
Janette K. Burgess

Frontiers in Pharmacology

doi 10.3389/fphar.2022.995051

5,054 views
13 citations

Editorial

Published on 03 Nov 2022

Editorial: Oxidative stress related to cellular metabolism in lung health and diseases

in Respiratory Pharmacology

Karuppusamy Arunachalam
Krishnan Anand
Subramanian Palanisamy
Vikas Anathy

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1015423

2,046 views
5 citations

Original Research

Published on 03 Nov 2022

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis

in Respiratory Pharmacology

Rong-Hong Guo
Hao Cheng
Xiao-Ying Zhang
Zhen Yu
Guang-Hui Wang
Shu-Ya Hao
Xiao-Peng Gao
Hong-Yan Wen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.986199

2,620 views
9 citations